Position in OCGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,045,672
+$920,407 QoQ
Shares Held
1,990,636
+69.5% QoQ
Ownership
0.587%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 147 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Derivatives in OCGN
reported options exposure · as of Dec 31, 2021CallValue
$0
CallShares
0
PutValue
$1,047,410
PutShares
230,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. OCGN ranks #170 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in OCGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,045,672 | 1,990,636 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,125,265 | 1,174,180 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $133,206 | 98,672 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $251,625 | 154,372 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $78,762 | 81,199 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $99,921 | 141,533 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $304,760 | 378,587 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $954,521 | 962,221 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $993,658 | 641,071 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $449,002 | 273,783 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $89,227 | 155,181 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $81,753 | 204,385 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $201,796 | 371,635 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $417,988 | 490,023 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,742,903 | 2,879,157 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,463,255 | 1,945,650 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,766,366 | 1,218,664 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,206,467 | 2,789,839 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,292,718 | 1,163,235 | Shares | Defined | 2022-02-08 | |
| 2021-12-31 | $1,047,410 | 230,200 | Put | Defined | 2022-02-08 | |
| 2021-09-30 | $726,500 | 101,184 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $162,986 | 22,700 | Put | Defined | 2021-11-15 | |
| 2021-06-30 | $20,770,398 | 2,586,600 | Put | Defined | 2021-09-13 | |
| 2021-06-30 | $3,449,374 | 429,561 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $279,645 | 41,185 | Shares | Defined | 2021-05-14 | |
| 2021-03-31 | $8,871,814 | 1,306,600 | Put | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||